EUVIMEDEUVIMED entdecken
Crossref

1,3,4-Oxadiazole Derivative: A Potential Anti-inflammatory and Antioxidant Agent in Experimental Autoimmune Encephalomyelitis

Syeda Rida Zainab, Jehan Zeb Khan, Syeda Anaa Batool, Humaira Nadeem, Muhammad Khalid Tipu, Humaira Fatima, Nadeem Ahmad, Zaheer Ul-Haq, Nadeem Irshad

Neurochemical Research · 2026

DOI: 10.1007/s11064-026-04669-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2026. Verfasst von Syeda Rida Zainab und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, 45320, Pakistan. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Antioxidants, Anti-Inflammatory Agents, Oxadiazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1,3,4-Oxadiazole derivatives have attracted substantial attention as promising therapeutic agents for neurodegenerative disorders due to their anti-inflammatory and neuroprotective properties. This study specifically examined a 1,3,4-oxadiazole derivative, i.e.,-{[5-(3-bromophenyl)-1, 3, 4-oxadiazol-2-yl] sulfanyl} ethan-1-ol (abbreviated as OX-1), in the context of multiple sclerosis (MS). Currently, approximately 2.8 million individuals worldwide are living with MS. The study demonstrates the therapeutic potential of OX-1 using the experimental autoimmune encephalomyelitis (EAE) model of MS. Neurobehavioral assessments indicate significant improvements in clinical scoring, motor deficits, muscular strength, and locomotor activity in EAE subjects. Imaging test reveal notable improvements in spinal deformity, further supporting the efficacy of the compound. Comprehensive analyses, including antioxidant assays, RT-PCR, and comet assays, confirm that OX-1 effectively reduces oxidative stress, accompanied by a significant decrease in cytokine expression. Histological examinations reveal critical pathological changes in the hippocampus, cortex, eyes, spinal cord, and optic nerve. The data demonstrate that this compound exhibits neuroprotective effects by activating the Nrf2/HO-1 pathway, thereby reducing oxidative stress and enhancing the antioxidant defense system. Additionally, it suppresses the TLR4/NF-κB pathway, significantly lowering pro-inflammatory cytokine production and immune cell infiltration. Furthermore, molecular docking and simulation studies demonstrate the binding interactions and potential modulatory effects of OX-1 on HO-1 and NF-κB. These results emphasize the therapeutic promise of OX-1 in effectively alleviating the clinical signs and symptoms associated with EAE-induced MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalAntioxidantsAnti-Inflammatory AgentsOxadiazolesAnimalsFemaleOxidative StressMice, Inbred C57BLMiceNF-E2-Related Factor 2

Stichwörter der Autor:innen

CytokinesEAE modelMotor deficitMultiple sclerosisNrf2/HO-1TLR4/NF-κB

Substanzen

AntioxidantsAnti-Inflammatory AgentsOxadiazoles1,3,4-oxadiazoleNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
  • University of Management and Technology, Sialkot, 52200, Pakistan.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Riphah International University, Islamabad, 44000, Pakistan.
  • H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, 45320, Pakistan. nirshad@qau.edu.pk.

Zitieren

APA

Zainab, S. R., Khan, J. Z., Batool, S. A., Nadeem, H., Tipu, M. K., Fatima, H., Ahmad, N., Ul-Haq, Z., & Irshad, N. (2026). 1,3,4-Oxadiazole Derivative: A Potential Anti-inflammatory and Antioxidant Agent in Experimental Autoimmune Encephalomyelitis. Neurochemical Research. https://doi.org/10.1007/s11064-026-04669-y

Vancouver

Zainab SR, Khan JZ, Batool SA, Nadeem H, Tipu MK, Fatima H, et al. 1,3,4-Oxadiazole Derivative: A Potential Anti-inflammatory and Antioxidant Agent in Experimental Autoimmune Encephalomyelitis. Neurochemical Research. 2026. doi:10.1007/s11064-026-04669-y

BibTeX
@article{Zainab2026,
  author = {Zainab, Syeda Rida and Khan, Jehan Zeb and Batool, Syeda Anaa and Nadeem, Humaira and Tipu, Muhammad Khalid and Fatima, Humaira and Ahmad, Nadeem and Ul-Haq, Zaheer and Irshad, Nadeem},
  title = {1,3,4-Oxadiazole Derivative: A Potential Anti-inflammatory and Antioxidant Agent in Experimental Autoimmune Encephalomyelitis},
  journal = {Neurochemical Research},
  year = {2026},
  doi = {10.1007/s11064-026-04669-y}
}
Kostenlos starten →